control group:transnasal injection of normal saline

3 trials

Sponsors

Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai tongji hospital, Shanghai Changhai Hospital

Conditions

Ischemic strokeParkinson’s disease

Early Phase 1

Evaluation of safety and efficacy of human neural stem cells in the treatment of early onset Parkinson's disease with motor complications

Active, not recruitingChiCTR1900024661

Shanghai tongji hospitalParkinson’s disease

Start: 2019-08-01Updated: 2021-12-13

Safety and efficacy of human neural stem cells in the treatment of Parkinson's disease patients after deep brain stimulation: a single center, randomized, double-blind, placebo-controlled clinical study

Active, not recruitingChiCTR2000036112

Shanghai Changhai HospitalParkinson’s disease

Start: 2020-10-10Updated: 2020-10-19

Phase 1

A single center randomized controlled trial for human-derived neural stem cell in the treatment of ischemic stroke

RecruitingChiCTR1900022741

Renji Hospital, Shanghai Jiao Tong University School of MedicineIschemic stroke

Start: 2019-06-01Updated: 2022-03-07

Related Papers

Efficacy and safety of human-derived neural stem cell in patients with ischaemic stroke: study protocol for a randomised controlled trial

BMJ Open2022-11-018 citations